1. Home
  2. DAKT vs CTMX Comparison

DAKT vs CTMX Comparison

Compare DAKT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$19.87

Market Cap

964.5M

Sector

Industrials

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.77

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
CTMX
Founded
1968
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
964.5M
977.1M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
DAKT
CTMX
Price
$19.87
$3.77
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$12.10
AVG Volume (30 Days)
231.9K
3.1M
Earning Date
03-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$608,932,000.00
$76,201,000.00
Revenue This Year
$12.06
N/A
Revenue Next Year
$9.16
$7.61
P/E Ratio
$26.67
$22.58
Revenue Growth
6.89
N/A
52 Week Low
$13.05
$1.72
52 Week High
$28.27
$8.21

Technical Indicators

Market Signals
Indicator
DAKT
CTMX
Relative Strength Index (RSI) 47.33 34.05
Support Level $18.99 $3.76
Resistance Level $20.40 $3.91
Average True Range (ATR) 0.56 0.22
MACD 0.12 -0.03
Stochastic Oscillator 41.88 9.87

Price Performance

Historical Comparison
DAKT
CTMX

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: